CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.58
14.49%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

DarioHealth Corp ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.38
Open* 1.5
1-Year Change* -69.26%
Day's Range* 1.44 - 1.6
52 wk Range 0.68-6.78
Average Volume (10 days) 116.10K
Average Volume (3 months) 3.66M
Market Cap 28.30M
P/E Ratio -100.00K
Shares Outstanding 27.21M
Revenue 23.55M
EPS -2.20
Dividend (Yield %) N/A
Beta 1.38
Next Earnings Date Mar 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 1, 2023 1.38 0.24 21.05% 1.14 1.39 1.14
Nov 30, 2023 1.19 -0.05 -4.03% 1.24 1.26 1.15
Nov 29, 2023 1.27 0.23 22.12% 1.04 1.28 1.04
Nov 28, 2023 1.02 -0.03 -2.86% 1.05 1.07 1.00
Nov 27, 2023 1.06 0.02 1.92% 1.04 1.09 1.02
Nov 24, 2023 1.03 0.04 4.04% 0.99 1.04 0.97
Nov 22, 2023 0.98 -0.03 -2.97% 1.01 1.03 0.98
Nov 21, 2023 1.02 -0.08 -7.27% 1.10 1.10 1.02
Nov 20, 2023 1.11 -0.19 -14.62% 1.30 1.30 1.09
Nov 17, 2023 1.17 0.18 18.18% 0.99 1.20 0.99
Nov 16, 2023 0.99 0.00 0.00% 0.99 1.02 0.99
Nov 15, 2023 1.02 0.05 5.15% 0.97 1.07 0.97
Nov 14, 2023 1.00 -0.04 -3.85% 1.04 1.06 0.99
Nov 13, 2023 1.01 -0.02 -1.94% 1.03 1.05 0.96
Nov 10, 2023 1.04 0.02 1.96% 1.02 1.11 1.02
Nov 9, 2023 1.06 -0.13 -10.92% 1.19 1.19 1.05
Nov 8, 2023 1.17 -0.09 -7.14% 1.26 1.27 1.15
Nov 7, 2023 1.29 -0.02 -1.53% 1.31 1.33 1.24
Nov 6, 2023 1.29 -0.05 -3.73% 1.34 1.40 1.27
Nov 3, 2023 1.32 0.29 28.16% 1.03 1.38 1.00

DarioHealth Corp. Events

Time (UTC) Country Event
Thursday, December 7, 2023

Time (UTC)

14:00

Country

IL

Event

DarioHealth Corp Annual Shareholders Meeting
DarioHealth Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, December 11, 2023

Time (UTC)

14:00

Country

IL

Event

DarioHealth Corp Annual Shareholders Meeting
DarioHealth Corp Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, March 7, 2024

Time (UTC)

13:30

Country

IL

Event

Q4 2023 DarioHealth Corp Earnings Release
Q4 2023 DarioHealth Corp Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 27.656 20.513 7.576 7.559 7.394
Revenue 27.656 20.513 7.576 7.559 7.394
Cost of Revenue, Total 18.001 16.55 5.063 4.962 5.629
Gross Profit 9.655 3.963 2.513 2.597 1.765
Total Operating Expense 88.931 97.007 37.479 25.264 25.082
Selling/General/Admin. Expenses, Total 46.816 63.238 27.983 16.61 15.777
Research & Development 19.649 17.219 4.433 3.692 3.676
Unusual Expense (Income) 4.465
Operating Income -61.275 -76.494 -29.903 -17.705 -17.688
Interest Income (Expense), Net Non-Operating -0.107 -0.151 0.507 -0.004 -0.115
Other, Net -0.807 -0.084 -0.049 -0.027
Net Income Before Taxes -62.189 -76.729 -29.445 -17.736 -17.803
Net Income After Taxes -62.193 -76.761 -29.445 -17.736 -17.803
Net Income Before Extra. Items -62.193 -76.761 -29.445 -17.736 -17.803
Net Income -62.193 -76.761 -29.445 -17.736 -17.803
Total Adjustments to Net Income -1.643 -2.005 -3.658 -3.155 -0.493
Income Available to Common Excl. Extra. Items -63.836 -78.766 -33.103 -20.891 -18.296
Income Available to Common Incl. Extra. Items -63.836 -78.766 -33.103 -20.891 -18.296
Diluted Net Income -63.836 -78.766 -33.103 -20.891 -18.296
Diluted Weighted Average Shares 23.635 16.5917 5.96331 2.26614 1.17064
Diluted EPS Excluding Extraordinary Items -2.70091 -4.74731 -5.55112 -9.21878 -15.629
Diluted Normalized EPS -2.57811 -4.71283 -5.55112 -9.21878 -15.629
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 6.152 7.066 6.809 6.605 6.183
Revenue 6.152 7.066 6.809 6.605 6.183
Cost of Revenue, Total 4.078 3.898 4.077 4.805 5.045
Gross Profit 2.074 3.168 2.732 1.8 1.138
Total Operating Expense 23.839 19.263 19.155 22.316 23.529
Selling/General/Admin. Expenses, Total 10.872 10.411 6.96 11.57 14.356
Research & Development 5.222 5.165 4.782 4.803 4.137
Operating Income -17.687 -12.197 -12.346 -15.711 -17.346
Interest Income (Expense), Net Non-Operating 1.621 -0.579 -0.244 0.093 0.062
Other, Net -0.519 -0.049 -0.024 -0.014 -0.743
Net Income Before Taxes -16.585 -12.825 -12.614 -15.632 -18.027
Net Income After Taxes -16.585 -12.825 -12.617 -15.632 -18.028
Net Income Before Extra. Items -16.585 -12.825 -12.617 -15.632 -18.028
Net Income -16.585 -12.825 -12.617 -15.632 -18.028
Total Adjustments to Net Income -1.691 0 -0.265 -0.494 -0.433
Income Available to Common Excl. Extra. Items -18.276 -12.825 -12.882 -16.126 -18.461
Income Available to Common Incl. Extra. Items -18.276 -12.825 -12.882 -16.126 -18.461
Diluted Net Income -18.276 -12.825 -12.882 -16.126 -18.461
Diluted Weighted Average Shares 28.1863 27.57 25.911 22.9732 22.426
Diluted EPS Excluding Extraordinary Items -0.6484 -0.46518 -0.49716 -0.70195 -0.8232
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.5183 -0.47283 -0.41348 -0.65241 -0.82346
Unusual Expense (Income) 3.667 -0.211 3.336 1.138 -0.009
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 65.524 45.605 34.128 22.939 13.313
Cash and Short Term Investments 49.522 36 28.777 20.586 11.177
Cash & Equivalents 49.357 35.808 28.59 20.395 10.997
Short Term Investments 0.165 0.192 0.187 0.191 0.18
Total Receivables, Net 6.899 1.71 1.624 0.672 0.759
Accounts Receivable - Trade, Net 6.416 1.31 0.124 0.672 0.168
Total Inventory 7.956 6.228 2.293 1.414 1.377
Prepaid Expenses 0.908 1.591 1.354 0.203
Other Current Assets, Total 0.239 0.076 0.08 0.064
Total Assets 119.191 100.771 35.407 24.569 14.089
Property/Plant/Equipment, Total - Net 1.994 0.989 1.074 1.413 0.733
Property/Plant/Equipment, Total - Gross 3.433 2.215 1.866 2.024
Accumulated Depreciation, Total -1.439 -1.226 -0.792 -0.611
Other Long Term Assets, Total 0.117 0.077 0.205 0.217 0.043
Total Current Liabilities 19.35 14.376 7.034 5.22 5.164
Accounts Payable 2.322 5.109 2.48 1.656 2.574
Accrued Expenses 6.885 8.072 3.33 2.341
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.32 1.195 1.224 1.223 2.59
Total Liabilities 39.192 15.222 7.256 5.675 5.164
Total Long Term Debt 18.105 0 0 0 0
Long Term Debt 18.105
Other Liabilities, Total 1.737 0.846 0.222 0.455 0
Total Equity 79.999 85.549 28.151 18.894 8.925
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.003 0.002 0.00081 0.00022 0.008
Additional Paid-In Capital 365.846 307.561 171.399 129.039 98.171
Retained Earnings (Accumulated Deficit) -285.85 -222.014 -143.248 -110.145 -89.254
Total Liabilities & Shareholders’ Equity 119.191 100.771 35.407 24.569 14.089
Total Common Shares Outstanding 25.7245 16.5734 8.11949 2.23565 1.83039
Total Preferred Shares Outstanding 0.00357 0.01193 0.01582 0 0
Other Equity, Total -0.00081 -0.00022
Goodwill, Net 41.64 41.64
Intangibles, Net 9.916 12.46
Current Port. of LT Debt/Capital Leases 8.823
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 56.211 65.777 55.476 65.524 71.582
Cash and Short Term Investments 44.273 52.995 43.318 49.522 57.257
Cash & Equivalents 43.878 52.602 38.789 49.357 57.081
Short Term Investments 0.395 0.393 4.529 0.165 0.176
Total Receivables, Net 6.467 6.868 5.281 8.046 6.563
Accounts Receivable - Trade, Net 4.533 4.821 2.797 6.416 4.521
Total Inventory 5.471 5.914 6.877 7.956 7.762
Total Assets 106.505 117.159 108.009 119.191 126.334
Property/Plant/Equipment, Total - Net 1.977 1.888 1.935 1.994 2.032
Goodwill, Net 41.64 41.64 41.64 41.64 41.64
Intangibles, Net 6.541 7.678 8.803 9.916 11.053
Other Long Term Assets, Total 0.136 0.176 0.155 0.117 0.027
Total Current Liabilities 8.106 8.076 17.617 19.35 11.524
Accounts Payable 1.929 1.451 1.883 2.322 1.982
Accrued Expenses 0.119 0.145 0.291 0.293 0.27
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.684 0.789 0.925 1.32 2.76
Total Liabilities 38.47 38.755 35.979 39.192 37.388
Total Long Term Debt 29 29.094 16.745 18.105 24.046
Other Liabilities, Total 1.364 1.585 1.617 1.737 1.818
Total Equity 68.035 78.404 72.03 79.999 88.946
Preferred Stock - Non Redeemable, Net
Common Stock 0.003 0.003 0.003 0.003 0.002
Additional Paid-In Capital 401.887 395.352 370.702 365.846 361.912
Retained Earnings (Accumulated Deficit) -333.855 -316.951 -298.675 -285.85 -272.968
Other Equity, Total
Total Liabilities & Shareholders’ Equity 106.505 117.159 108.009 119.191 126.334
Total Common Shares Outstanding 27.2152 26.7847 25.8753 25.7245 23.291
Total Preferred Shares Outstanding 0.01896 0.01896 0.00356 0.00357 0.00991
Payable/Accrued 5.374 5.691 5.935 6.592 6.512
Long Term Debt 29 29.094 16.745 18.105 24.046
Current Port. of LT Debt/Capital Leases 0 8.583 8.823
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -62.193 -76.761 -29.445 -17.736 -17.803
Cash From Operating Activities -47.845 -50.409 -17.736 -15.725 -11.47
Cash From Operating Activities 0.356 0.282 0.19 0.183 0.207
Non-Cash Items 20.108 26.322 11.369 2.625 3.758
Changes in Working Capital -10.477 -3.287 0.15 -0.797 2.368
Cash From Investing Activities -0.573 -8.134 -1.622 -0.113 0.006
Capital Expenditures -0.573 -0.261 -0.118 -0.098 -0.071
Other Investing Cash Flow Items, Total 0 -7.873 -1.504 -0.015 0.077
Cash From Financing Activities 61.94 65.766 27.548 25.247 18.743
Issuance (Retirement) of Stock, Net 38.154 65.766 27.548 25.247 18.743
Net Change in Cash 13.522 7.223 8.19 9.409 7.279
Amortization 4.361 3.035
Cash Interest Paid 1.876
Issuance (Retirement) of Debt, Net 23.786
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -12.825 -62.193 -49.576 -33.944 -15.916
Cash From Operating Activities -4.757 -47.845 -39.904 -29.209 -18.094
Cash From Operating Activities 0.097 0.356 0.243 0.154 0.07
Amortization 1.113 4.361 3.224 2.087 0.963
Non-Cash Items 4.585 20.108 13.818 9.303 5.35
Changes in Working Capital 2.273 -10.477 -7.613 -6.809 -8.561
Cash From Investing Activities -4.362 -0.573 -0.514 -0.34 -0.181
Capital Expenditures -0.074 -0.573 -0.514 -0.34 -0.181
Other Investing Cash Flow Items, Total -4.288 0 0 0 0
Cash From Financing Activities -1.389 61.94 61.675 61.675 38.023
Issuance (Retirement) of Stock, Net 38.154 37.889 37.889 38.023
Net Change in Cash -10.508 13.522 21.257 32.126 19.748
Cash Interest Paid 1.072 1.876 0.969 0.181
Issuance (Retirement) of Debt, Net -1.389 23.786 23.786 23.786
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Nantahala Capital Management, LLC Hedge Fund 8.8854 2418507 0 2023-06-30 MED
Phoenix Investment and Finances Ltd Investment Advisor 4.9268 1341027 0 2023-06-30 MED
More Investment House Ltd. Investment Advisor/Hedge Fund 4.7339 1288518 -178202 2023-09-30 LOW
Appian Way Asset Management LP Investment Advisor/Hedge Fund 4.7069 1281158 258376 2023-06-30 HIGH
Clal Insurance Enterprises Holdings Ltd. Investment Advisor 3.9185 1066561 0 2023-06-30 LOW
Kershner Trading Americas, L.L.C. Corporation 3.8687 1053024 -180500 2023-09-08 LOW
Raphael (Erez) Individual Investor 2.9484 802521 91777 2023-03-03 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.0601 288549 0 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9188 250099 55704 2023-06-30 LOW
Ben-David (Zvi) Individual Investor 0.9139 248765 26455 2023-03-03 LOW
Stern (Adam K.) Individual Investor 0.6526 177634 122026 2023-03-03 MED
Bacher (Dror) Individual Investor 0.6229 169533 40515 2023-03-03 MED
Shaked (Yoav) Individual Investor 0.441 120042 9102 2023-03-03 LOW
MAI Capital Management, LLC Investment Advisor/Hedge Fund 0.3946 107394 -38406 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.3887 105800 -37187 2023-06-30 LOW
Shay Capital LLC Hedge Fund 0.3674 100000 0 2023-06-30 HIGH
LPL Financial LLC Investment Advisor 0.3391 92301 5735 2023-06-30 LOW
Karah (Hila) Individual Investor 0.3095 84255 10025 2023-03-03 MED
Matheis (Dennis) Individual Investor 0.282 76747 -29127 2023-03-03 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.248 67497 0 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DarioHealth Corp. Company profile

About DarioHealth Corp

DarioHealth Corp.(DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. DarioHealth products include Dario blood glucose monitoring, Dario Blood Pressure Monitoring System, and Dario Smart Scale. The Dario blood glucose monitoring device is a system that measure sugar levels. The Dario Smart Scale is a blood pressure monitoring system used to measure blood pressure and stored in a digital logbook in the Dario App. It offers modular platform integrating digital therapeutics, coaching, devices, and care providers. Its suite of offerings includes Dario Tools, DarioEngage, and Dario Loop.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DarioHealth Corp revenues increased from $7.6M to $20.5M. Net loss applicable to common stockholders increased from $33.1M to $78.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Marketing and Pre-Production Cost increase from $12.5M to $33.7M (expense).

Equity composition

Common Stock $0.0001 Par, Shares auth. 45M and o/s 19,240,234 issd. Insiders own approx. 14.03% (after the IPO). If no information is provided, use TBA. 10/14 1-for-5 reverse stock split. 03/2016, 1-For-18 Reverse Stock Split.

Industry: Medical Equipment, Supplies & Distribution (NEC)

18 W 18Th St., 5Th Floor
NEW YORK
NEW YORK 10011
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

BTC/USD

41,951.60 Price
+5.490% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

15,827.20 Price
-1.070% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.63 Price
+0.170% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,029.42 Price
-2.080% 1D Chg, %
Long position overnight fee -0.0200%
Short position overnight fee 0.0118%
Overnight fee time 22:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading